Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Liminal FAILS to find partner for Ryplazim
View:
Post by james700 on May 13, 2021 3:50pm

Liminal FAILS to find partner for Ryplazim

Listen to the Q4 report around the 14 or 15 minute mark. They have been searching for a partner to develop Ryplazim, but have found NO ONE willing to put the money up to do this. Think about that before listening to NEWCAMO (Mr. Blah blah blah buy buy buy) They actually mention selling or shutting down Ryplazim, to save money as they only have enough left for 9 more months. Don't TRUST these thieves who charged the company $150M of FUTURE, repeat future, interest. That's right Thomvest extended the terms of a loan, due in sept 2019, out to fall of 2024. They then called the loan the following spring in April and demanded all FIVE YEARS of future interest at 19-20% interest rate. Then used that $150M to purchase shares at 1.5 cents each, reverse split became a $15 stock. Presently trading at $4 which is actually 0.4 cents... Not even half a cent. BEWARE NEW INVESTORS!!!!
Comment by stockbuphoon on May 13, 2021 8:52pm
Bingo!